Cancer Care Ontario | Cancer Care Ontario

51 Results

Guidelines and Advice

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Status: In-Review
ID: 3-22
Version: N/A

Apr 2020

Guidelines and Advice

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Status: In-Review
ID: 7-13

Oct 2017

Guidelines and Advice

The Management of Depression in Patients with Cancer

Status: In-Review
ID: 19-4

May 2015

Guidelines and Advice

Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer

Status: In-Review
ID: GL MOTAC-4
Version: 2

Jan 2022

Guidelines and Advice

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020

Guidelines and Advice

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Status: In-Review
ID: GL 2-33

Jun 2022

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Guidelines and Advice

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Status: In-Review
ID: GL END 3-23
Version: N/A

Oct 2021

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Guidelines and Advice

The Organization of Colposcopy Services in Ontario: Recommended Framework

Status: In-Review
ID: 15-12
Version: 2

Jan 2015

Guidelines and Advice

Active Surveillance for the Management of Localized Prostate Cancer

Status: In-Review
ID: 17-9

Dec 2014

Guidelines and Advice

Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario

Status: In-Review
ID: 16-4

May 2015

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

The Management of Depression in Patients with Cancer

Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

The Organization of Colposcopy Services in Ontario: Recommended Framework

Active Surveillance for the Management of Localized Prostate Cancer

Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario

Pages